Cargando…

Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma

OBJECTIVE: To investigate the potential role of protease-activated receptor 2 (PAR2) in the prognosis of hepatocellular carcinoma (HCC). METHODS: A total of 202 HCC patients who underwent liver resections were included. Tissue microarray was established with specimens of both HCC and paired adjacent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Peng, Yang, Na, Xu, Li, Zhao, Fangfang, Zhang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873753/ https://www.ncbi.nlm.nih.gov/pubmed/31768188 http://dx.doi.org/10.1186/s13027-019-0256-3

Ejemplares similares

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma
por: Wang, Li, et al.
Publicado: (2016)

Increased Expression of miR-487b Is Associated With Poor Prognosis and Tumor Progression of HBV-Related Hepatocellular Carcinoma
por: Cao, Xiangang, et al.
Publicado: (2020)

Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis
por: Liu, Miao, et al.
Publicado: (2017)

SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2015)

Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis
por: Zhou, Hua, et al.
Publicado: (2018)

CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis
por: Gu, Xuefeng, et al.
Publicado: (2019)

Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma
por: Zeng, Zhen, et al.
Publicado: (2011)

Increased expression of G9A contributes to carcinogenesis and indicates poor prognosis in hepatocellular carcinoma
por: Qin, Jian, et al.
Publicado: (2018)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
por: Lin, Kai‐Rong, et al.
Publicado: (2018)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

ROCK2 Polymorphism and Expression Contribute to Increased Susceptibility and Poor Prognosis in Hepatocellular Carcinoma
por: Qin, Lifeng, et al.
Publicado: (2022)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
por: Wei, Yanyan, et al.
Publicado: (2018)

Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma
por: Hu, Pingan, et al.
Publicado: (2019)

Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma
por: Wei, Tao, et al.
Publicado: (2014)

Increased Expression of Myeloid-Derived Suppressor Cells in Patients with HBV-Related Hepatocellular Carcinoma
por: Li, Tianyu, et al.
Publicado: (2020)

Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma
por: Chen, Yuanyuan, et al.
Publicado: (2016)

Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma
por: Wang, Kunyuan, et al.
Publicado: (2018)

The impact of thrombocytopenia on prognosis of HBV-related small hepatocellular carcinoma: a propensity score matching analysis
por: Peng, Wei, et al.
Publicado: (2021)

Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection
por: Zhang, Xia, et al.
Publicado: (2016)

The diagnostic and prognostic implications of PRKRA expression in HBV-related hepatocellular carcinoma
por: Hu, Yi-Min, et al.
Publicado: (2022)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma
por: Zhang, Ning, et al.
Publicado: (2022)

HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis
por: Dong, Mei-Ling, et al.
Publicado: (2022)

Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Han, Qunying, et al.
Publicado: (2021)

Increased expression of insulin-like growth factor-1 receptor predicts poor prognosis in patients with hepatocellular carcinoma
por: Zhang, Zhiquan, et al.
Publicado: (2019)

HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case–control study
por: Li, Zhonghu, et al.
Publicado: (2016)

Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinoma
por: Cai, Shao-hang, et al.
Publicado: (2017)

Co-expression of Piwil2/Piwil4 in nucleus indicates poor prognosis of hepatocellular carcinoma
por: Zeng, Guangping, et al.
Publicado: (2016)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2022)

Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients
por: Gu, Xiaobin, et al.
Publicado: (2016)

Germline Variants and Genetic Interactions of Several EMT Regulatory Genes Increase the Risk of HBV-Related Hepatocellular Carcinoma
por: Liu, Wen-Xuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d0j0u2qfakrecoul4cnn184aaa